{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/nausea-vomiting-in-pregnancy/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"845aae6a-8e35-57f1-b583-4763434044df","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field f577356d-9aed-4cd7-9034-3001e6c07a34 --><h2>Update</h2><!-- end field f577356d-9aed-4cd7-9034-3001e6c07a34 -->","summary":null,"htmlStringContent":"<!-- begin item 35609cde-f2f3-4855-b255-1593965d88ba --><!-- end item 35609cde-f2f3-4855-b255-1593965d88ba -->","topic":{"id":"5d1ac05e-2e14-5b50-9a55-84ebd62fb88a","topicId":"866e168a-d1cc-4f14-ae38-2264dad4909d","topicName":"Nausea/vomiting in pregnancy","slug":"nausea-vomiting-in-pregnancy","lastRevised":"Last revised in November 2020","chapters":[{"id":"2ed30ea1-6303-508e-bc93-066f8ffbbba6","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"81163ec6-a53e-53b1-9990-910cceb0be62","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9f99e883-ffa1-5d97-b703-d5bfbd68f8d5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"81c02d2d-db72-591c-9cac-e581388698c4","slug":"changes","fullItemName":"Changes"},{"id":"845aae6a-8e35-57f1-b583-4763434044df","slug":"update","fullItemName":"Update"}]},{"id":"21afb631-a6c0-5829-b00a-3b33bef92b50","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"61081bb4-4afa-59ad-8401-21a133c7ac1e","slug":"goals","fullItemName":"Goals"},{"id":"5e20514d-0378-56ab-a9c4-6adb3b054200","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"5af11c90-393d-59dd-9a48-c750bc1a8a14","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"51bcef1b-8089-52c9-92cc-1fa55932d88b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ef8fc985-dc5b-58a5-a2ff-ca6e9d55cfb8","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f559ccd0-5b31-5044-9e75-d75ab6224e12","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2664bbce-4231-58ba-94b3-9154bbe463ce","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"474f1c82-889d-5487-9620-c2c4c6869f1b","slug":"definition","fullItemName":"Definition"},{"id":"8eb8a14e-f0bc-5bde-941f-077c2ebf80e8","slug":"causes","fullItemName":"Causes"},{"id":"6086e58d-ce8f-56ba-8bc9-6769de656e20","slug":"associated-factors","fullItemName":"Associated factors"},{"id":"843ada21-2019-53fe-96b9-02ac02e7d0f2","slug":"prevalence","fullItemName":"Prevalence"},{"id":"87b6f2c0-0cd6-59f3-9359-e145dc966385","slug":"complications","fullItemName":"Complications"}]},{"id":"d56e419a-1cce-586b-b99b-a5b8a8990006","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"1f17249a-f4a8-55a7-aac0-221f3958f18f","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"b917da16-f352-5806-8109-438dbc9bbf0b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"92cdc482-cd10-5234-96f9-a47cf0d7a2d1","fullItemName":"Management","slug":"management","subChapters":[{"id":"110c4bdc-fe27-5536-9a99-bfbcf04edc46","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"93dd4a9b-e268-51a6-ad4d-89d5e9f8a3ab","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"f416e06b-d171-5ff0-8c08-5bc1edd42843","slug":"cyclizine","fullItemName":"Cyclizine"},{"id":"130049ea-689b-545a-a2c3-05f0dd6e75a9","slug":"metoclopramide","fullItemName":"Metoclopramide"},{"id":"b1e3f566-e2f8-55a2-989a-e0a05d5ec1e2","slug":"ondansetron","fullItemName":"Ondansetron"},{"id":"5ab79693-69e2-58b9-b27b-5ccf74d1a7b5","slug":"prochlorperazine","fullItemName":"Prochlorperazine"},{"id":"715f035d-267f-5933-b2b0-7d3ee3bd6430","slug":"promethazine","fullItemName":"Promethazine"}]},{"id":"85b35812-d5b1-58c1-83b2-54c180386588","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"1a1884de-e81c-54af-b11f-6b0868c50cc8","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8a6cb0f6-92e2-57f4-9a1e-bf9e54371e08","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"4dc13c44-10ce-581a-a0a4-039b81c0c21e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"cb1eb43f-2d9f-59be-8318-3bd84b8d0c3f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"4b024ff4-e12a-55bd-ae23-668d6ca9e645","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"e5cef950-067b-517f-9adb-2be42bf3be6f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"dbe95893-89e8-5737-9b03-95b5280f9823","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"9f99e883-ffa1-5d97-b703-d5bfbd68f8d5","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"26698bf2-5fcd-53d4-91b3-009ba9af836b","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 879c0723-9b24-402c-94e6-ddd8919f0f9a --><h3>New evidence</h3><!-- end field 879c0723-9b24-402c-94e6-ddd8919f0f9a -->","summary":null,"htmlStringContent":"<!-- begin item 53530d5a-1c0e-4d5d-affc-5165e0e12cf9 --><!-- begin field 2a9e5cc4-c2bf-4784-a595-b8adf7ac8701 --><h3>Evidence-based guidelines</h3><!-- end field 2a9e5cc4-c2bf-4784-a595-b8adf7ac8701 --><!-- begin field 276c47aa-9d4f-4ae3-9ef0-b08a8857d3a9 --><p>No new evidence-based guidelines since 1 May 2017.</p><!-- end field 276c47aa-9d4f-4ae3-9ef0-b08a8857d3a9 --><!-- begin field f4e06a02-ac4d-42ee-96a5-f1a34b1f3f55 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field f4e06a02-ac4d-42ee-96a5-f1a34b1f3f55 --><!-- begin field bb544b41-f430-4b7f-a8f8-50ed62f25e2e --><p>No new HTAs since 1 May 2017.</p><!-- end field bb544b41-f430-4b7f-a8f8-50ed62f25e2e --><!-- begin field 757dbd94-899c-4dbf-9a62-cf2a6a27de4e --><h3>Economic appraisals</h3><!-- end field 757dbd94-899c-4dbf-9a62-cf2a6a27de4e --><!-- begin field a029bd60-78c0-4455-979d-a4696515c023 --><p>No new economic appraisals relevant to England since 1 May 2017.</p><!-- end field a029bd60-78c0-4455-979d-a4696515c023 --><!-- begin field fa2cd96c-d98a-4c94-81f2-93bff3ec03cf --><h3>Systematic reviews and meta-analyses</h3><!-- end field fa2cd96c-d98a-4c94-81f2-93bff3ec03cf --><!-- begin field 77725a34-5376-4534-b53d-bc6f77ef0cca --><p>UKTIS (2019) Ondansetron in pregnancy – updated UK Teratology Information Service (UKTIS) healthcare professional monograph and patient information leaflet. UKTIS. <a href=\"http://www.uktis.org/\" data-hyperlink-id=\"db947e67-71b5-4afa-9b69-aae200ac52b6\">www.uktis.org</a> [<a href=\"http://www.uktis.org/docs/Ondansetron%20UKTIS%20Response%20Statement.pdf\" data-hyperlink-id=\"7e0c7e5e-9820-4b50-943e-aae200ac5324\">Free Full-text</a>]</p><!-- end field 77725a34-5376-4534-b53d-bc6f77ef0cca --><!-- begin field ffe5b6a2-0f5a-445a-97e1-98865a36b763 --><h3>Primary evidence</h3><!-- end field ffe5b6a2-0f5a-445a-97e1-98865a36b763 --><!-- begin field f75f3634-9f42-4d8b-b82b-6d0344ad9b01 --><p>No new randomized controlled trials published in the major journals since 1 May 2017.</p><!-- end field f75f3634-9f42-4d8b-b82b-6d0344ad9b01 --><!-- end item 53530d5a-1c0e-4d5d-affc-5165e0e12cf9 -->","subChapters":[]},{"id":"f9438318-eac9-5bf2-9d50-26cdadd1efd1","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field 4d178062-cffd-4296-b03d-0fe8e1bf690f --><h3>New policies</h3><!-- end field 4d178062-cffd-4296-b03d-0fe8e1bf690f -->","summary":null,"htmlStringContent":"<!-- begin item 041a312b-ae3f-4e33-b242-69bc0f4cbece --><!-- begin field ca159f70-aa9b-4cdc-8e60-4218801f8fb4 --><p>No new policies since 1 May 2017.</p><!-- end field ca159f70-aa9b-4cdc-8e60-4218801f8fb4 --><!-- end item 041a312b-ae3f-4e33-b242-69bc0f4cbece -->","subChapters":[]},{"id":"3911899f-5a96-5b07-934f-752679a889db","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field ca060155-e155-40c4-8636-257407eaadf8 --><h3>New safety alerts</h3><!-- end field ca060155-e155-40c4-8636-257407eaadf8 -->","summary":null,"htmlStringContent":"<!-- begin item cd804c13-564d-4bc6-b1a0-7567bd65b9e7 --><!-- begin field a711fd21-a63f-4839-be50-acb7a369a7bd --><p>No new safety alerts since 1 May 2017.</p><!-- end field a711fd21-a63f-4839-be50-acb7a369a7bd --><!-- end item cd804c13-564d-4bc6-b1a0-7567bd65b9e7 -->","subChapters":[]},{"id":"9329401a-5c94-5d63-8fe0-576b4b80c02a","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field f7e1ab92-9df5-4fde-9e71-4d6f1d85405c --><h3>Changes in product availability</h3><!-- end field f7e1ab92-9df5-4fde-9e71-4d6f1d85405c -->","summary":null,"htmlStringContent":"<!-- begin item 540e5ebe-78dc-42d2-b994-c2ae010f14f4 --><!-- begin field e341b890-7f6d-4d96-aff6-35942363c5bd --><ul><li>Xonvea is licensed for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management. For more information see <a href=\"https://www.medicines.org.uk/emc/product/9344/smpc\" data-hyperlink-id=\"cd688056-d2f2-46d9-8aa9-a97000dbe395\">here</a>. </li></ul><!-- end field e341b890-7f6d-4d96-aff6-35942363c5bd --><!-- end item 540e5ebe-78dc-42d2-b994-c2ae010f14f4 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}